Literature DB >> 9041643

Intrachain disulfide bond in the core hinge region of human IgG4.

J W Bloom1, M S Madanat, D Marriott, T Wong, S Y Chan.   

Abstract

IgG is a tetrameric protein composed of two copies each of the light and heavy chains. The four-chain structure is maintained by strong noncovalent interactions between the amino-terminal half of pairs of heavy-light chains and between the carboxyl-terminal regions of the two heavy chains. In addition, interchain disulfide bonds link each heavy-light chain and also link the paired heavy chains. An engineered human IgG4 specific for human tumor necrosis factor-alpha (CDP571) is similar to human myeloma IgG4 in that it is secreted as both disulfide bonded tetramers (approximately 75% of the total amount of IgG) and as tetramers composed of nondisulfide bonded half-IgG4 (heavy chain disulfide bonded to light chain) molecules. However, when CDP571 was genetically engineered with a proline at residue 229 of the core hinge region rather than serine, CDP571 (S229P), or with an IgG1 rather than IgG4 hinge region, CDP571(gamma 1), only trace amounts of nondisulfide bonded half-IgG tetramers were observed. Trypsin digest reversephase HPLC peptide mapping studies of CDP571 and CDP571(gamma 1) with on-line electrospray ionization mass spectroscopy supplemented with Edman sequencing identified the chemical factor preventing inter-heavy chain disulfide bond formation between half-IgG molecules: the two cysteines in the IgG4 and IgG1 core hinge region (CPSCP and CPPCP, respectively) are capable of forming an intrachain disulfide bond. Conformational modeling studies on cyclic disulfide bonded CPSCP and CPPCP peptides yielded energy ranges for the low-energy conformations of 31-33 kcal/mol and 40-42 kcal/mol, respectively. In addition, higher torsion and angle bending energies were observed for the CPPCP peptide due to backbone constraints caused by the extra proline. These modeling results suggest a reason why a larger fraction of intrachain bonds are observed in IgG4 rather than IgG1 molecules: the serine in the core hinge region of IgG4 allows more hinge region flexibility than the proline of IgG1 and thus may permit formation of a stable intrachain disulfide bond more readily.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041643      PMCID: PMC2143633          DOI: 10.1002/pro.5560060217

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

1.  The structural basis for the functional versatility of immunoglobulin G1.

Authors:  K J Dorrington
Journal:  Can J Biochem       Date:  1978-12

2.  Three-dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution.

Authors:  A Holmgren; B O Söderberg; H Eklund; C I Brändén
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Why is DsbA such an oxidizing disulfide catalyst?

Authors:  U Grauschopf; J R Winther; P Korber; T Zander; P Dallinger; J C Bardwell
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 5.  Molecular size and conformation of immunoglobulins.

Authors:  K J Dorrington; C Tanford
Journal:  Adv Immunol       Date:  1970       Impact factor: 3.543

6.  An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G.

Authors:  J G Petersen; K J Dorrington
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

7.  The primary structure of calf thymus glutaredoxin. Homology with the corresponding Escherichia coli protein but elongation at both ends and with an additional half-cystine/cysteine pair.

Authors:  I M Klintrot; J O Höög; H Jörnvall; A Holmgren; M Luthman
Journal:  Eur J Biochem       Date:  1984-11-02

8.  Rat liver thioredoxin and thioredoxin reductase: purification and characterization.

Authors:  M Luthman; A Holmgren
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

9.  The primary structure of Escherichia coli glutaredoxin. Distant homology with thioredoxins in a superfamily of small proteins with a redox-active cystine disulfide/cysteine dithiol.

Authors:  J O Höög; H Jörnvall; A Holmgren; M Carlquist; M Persson
Journal:  Eur J Biochem       Date:  1983-10-17

10.  [Synthesis and stability of some cyclic cystine peptides Cys-(X)n-Cys (author's transl)].

Authors:  U Weber; P Hartter
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-02
View more
  41 in total

1.  Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.

Authors:  James T Heads; Ralph Adams; Lena E D'Hooghe; Matt J T Page; David P Humphreys; Andrew G Popplewell; Alastair D Lawson; Alistair J Henry
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

Review 2.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

3.  Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation.

Authors:  Yi Wang; Qiaozhen Lu; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal:  Anal Chem       Date:  2011-03-23       Impact factor: 6.986

4.  Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.

Authors:  Shirley J Peters; C Mark Smales; Alistair J Henry; Paul E Stephens; Shauna West; David P Humphreys
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

5.  Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.

Authors:  Lily Pei-Yao Liu-Shin; Adam Fung; Arun Malhotra; Gayathri Ratnaswamy
Journal:  MAbs       Date:  2018-10-19       Impact factor: 5.857

6.  The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.

Authors:  John-Paul Silva; Olivia Vetterlein; Joby Jose; Shirley Peters; Hishani Kirby
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

7.  Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.

Authors:  Aran F Labrijn; Joyce I Meesters; Bart E C G de Goeij; Ewald T J van den Bremer; Joost Neijssen; Muriel D van Kampen; Kristin Strumane; Sandra Verploegen; Amitava Kundu; Michael J Gramer; Patrick H C van Berkel; Jan G J van de Winkel; Janine Schuurman; Paul W H I Parren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

8.  Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure.

Authors:  Ian C Wilkinson; Susan B Fowler; Leeann Machiesky; Kenneth Miller; David B Hayes; Morshed Adib; Cheng Her; M Jack Borrok; Ping Tsui; Matthew Burrell; Dominic J Corkill; Susanne Witt; David C Lowe; Carl I Webster
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

Review 9.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

10.  Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo.

Authors:  Aran F Labrijn; Antonio Ortiz Buijsse; Ewald T J van den Bremer; Annemiek Y W Verwilligen; Wim K Bleeker; Susan J Thorpe; Joep Killestein; Chris H Polman; Rob C Aalberse; Janine Schuurman; Jan G J van de Winkel; Paul W H I Parren
Journal:  Nat Biotechnol       Date:  2009-07-20       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.